NVIDIA
Corporate investorPortfolio in 4 countries: 6 funded startups tracked by Uback, 4 of them in a ranking.
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Abridge | #3 Clinical software | Healthtech › Clinical software › Clinical software | Series E extension · USD 316M · Apr 2026 | Unicorn |
| Poolside | #4 Coding agents | Artificial intelligence › Agents › Coding agents | Series B · USD 500M · Oct 2024 | Unicorn |
| ArsenalBio | #4 Gene & cell therapies | Healthtech › Biotech › Gene & cell therapies | Series C · USD 325M · Sep 2024 | Unicorn |
| Basecamp Research | #10 AI drug discovery | Healthtech › Biotech › AI drug discovery | Series C · USD 140M · Sep 2026 | Hundreds of M$ |
| Point2 Technology | Radar | Semiconductors › data-centre interconnect | Series B extension · Series B total USD 136M · Aug 2026 | Not estimated |
| Uniphore | Radar | AI › enterprise conversational AI | Series F · USD 260M · Oct 2025 | Not estimated |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
Co-investors
AMD · Snowflake · Databricks · LB Investment · Arm · S32 · Anthology Fund · Andreessen Horowitz · Khosla Ventures · Bain Capital Ventures · DST Global · eBay · ARCH Venture Partners · Regeneron · T. Rowe Price · Bristol Myers Squibb · SoftBank Vision Fund
Investors that joined the same rounds, as reported by public sources.
Sources. abridge.com, arsenalbio.com, biopharmadive.com, bloomberg.com, business-standard.com, finsmes.com, forgeglobal.com, fortune.com, sacra.com, siliconangle.com, thenextweb.com, as cited on each company’s profile.
Last updated: Oct 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.